Agastiya Biotech
PrivateLast Round
Series A
Mar 15, 2026
Company Overview
Agastiya Biotech is a biotechnology company that develops novel small molecule oncology therapeutics for the treatment of various cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Agastiya Biotech Comparables
Compare Agastiya Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aspera Biomedicines | 81% | |
| Avenzoar Pharmaceuticals | 78% | |
| StemSynergy Therapeutics, Inc. | 78% | |
Agastiya Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 15, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 30, 2024
Monthly visitors grew 463% MoM, from 71 to 400.
Agastiya Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Agastiya Biotech's valuation, stock price, and market status.